Sanofi to pay more than 25 million dollar to resolve corruption charges: SEC
WASHINGTON: French pharmaceutical giant Sanofi will pay more than $25 million to settle charges that its Kazakhstan and the Middle East subsidiaries made corrupt payments to win business, the top U.S. securities regulator said on Tuesday.
Without admitting or denying the findings, the company agreed to pay $17.5 million in disgorgement, $2.7 million in prejudgment interest and a civil penalty of $5 million, the Securities and Exchange Commission said.
(Reporting by Lisa Lambert; Editing by Chizu Nomiyama)
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd